Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Se Hoon Oh , Joon Hyoek Lee , Ji Won Hwang , Hye Young Kim , Chang Hoon Lee , Geum Youn Gwak , Moon Seok Choi , Kwang Chul Koh , Seung Woon Paik , Byung Chul Yoo

Clin Mol Hepatol. 2009;15(3):362-369. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.362

View: 4568 Download: 40 Crossref: 6

A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization

Young Kul Jung , Jong Eun Yeon , Chung Ho Kim , Hyun Jung Lee , Young Sun Lee , Eileen L. Yoon , Eun Suck Jung , Jong Hwan Choi , Ji Hoon Kim , Kwan Soo Byun

Clin Mol Hepatol. 2009;15(3):357-361. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.357

View: 6441 Download: 36

3

Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated Liver cirrhosis

Sung Hoa Lee, M.D., Seung Ha Park, M.D., Go Woon Kim, M.D., Woo Jin Lee, M.D., Won Ki Hong, M.D., Myeong Shin Ryu, M.D., Kyu Tae Park, M.D., Min Young Lee, M.D., Chan Woo Lee, M.D., Jin Ho Kim, M.D., Yong Mook Kim, M.D., Sung Jung Kim, M.D., Gwang Ho Baik, M.D., Jin Bong Kim, M.D., Dong Joon Kim, M.D.

Clin Mol Hepatol. 2009;15(3):350-356. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.350

View: 5302 Download: 30 Crossref: 3

Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response

Soung Won Jeong, M.D., Jin Dong Kim, M.D. Hyun Young Woo, M.D. Chan Ran You, M.D. Sung Won Lee, M.D. Myeong Jun Song, M.D. Jung Won Jang, M.D. Si Hyun Bae, M.D. Jong Young Choi, M.D. Seung Kew Yoon, M.D.

Clin Mol Hepatol. 2009;15(3):338-349. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.338

View: 4719 Download: 24 Crossref: 11

Efficacy of 48-week clevudine therapy for chronic hepatitis B

Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D., Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D., Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.

Clin Mol Hepatol. 2009;15(3):331-337. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.331

View: 4872 Download: 23 Crossref: 8

Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization

Sung Hoon Kim, M.D., Young-Hwa Chung, M.D. Soo Hyun Yang, M.D., Jeong A Kim, M.S. Myoung Kuk Jang, M.D. Sung Eun Kim, M.D. Danbi Lee, M.D. Sae Hwan Lee, M.D. Don Lee, M.D. Kang Mo Kim, M.D. Young Suk Lim, M.D. Han Chu Lee, M.D. Yung Sang Lee, M.D. Dong Jin Suh, M.D.

Clin Mol Hepatol. 2009;15(3):320-330. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.320

View: 5368 Download: 44 Crossref: 17

Haplotype analysis and possible founder effect at the R778L mutation of the ATP7B gene in Korean patients with Wilson`s disease

Sun Hwan Bae, M.D.*, Jong Won Kim, M.D. Jeong Kee Seo, M.D.

Clin Mol Hepatol. 2009;15(3):309-319. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.309

View: 4556 Download: 68 Crossref: 6

2

Molecular targeting for treatment of advanced hepatocellular carcinoma

Il Han Song

Clin Mol Hepatol. 2009;15(3):299-308. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.299

View: 5540 Download: 36 Crossref: 6

1

Haplotype analysis at R778L mutation of ATP7B gene in Korean patients with Wilson disease

Hyun Seok Jin , Berm Seok Oh

Clin Mol Hepatol. 2009;15(3):295-298. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.295

View: 4251 Download: 42

9

2009 EASL Highlights : Topics related to alcoholic Liver disease

Jin Dong Kim

Clin Mol Hepatol. 2009;15(2):280-284. Published online January 1, 1970

View: 2059 Download: 16

2009 EASL Highlights : Topics related to nonalcoholic fatty Liver disease

Joon Ho Moon

Clin Mol Hepatol. 2009;15(2):276-279. Published online January 1, 1970

View: 2022 Download: 13

2009 EASL Highlights : Topics related to the treatment of hepatocellular carcinoma

Hyun Young Woo

Clin Mol Hepatol. 2009;15(2):271-275. Published online January 1, 1970

View: 2066 Download: 13

2009 EASL Highlights : Topics related to hepatocellular carcinoma

Jae Seok Hwang

Clin Mol Hepatol. 2009;15(2):268-270. Published online January 1, 1970

View: 2108 Download: 14

2009 EASL Highlights : Topics related to Liver cirrhosis (ascites and hepatorenal syndrome in Liver cirrhosis)

Gab Jin Cheon

Clin Mol Hepatol. 2009;15(2):261-267. Published online January 1, 1970

View: 2042 Download: 14

2009 EASL Highlights : Topics related to Liver cirrhosis (variceal bleeding, portal hypertension, encephalopathy)

June Sung Lee

Clin Mol Hepatol. 2009;15(2):257-260. Published online January 1, 2000

View: 1993 Download: 14

2009 EASL Highlights : Topics related to hepatic fibrosis

Jong In Yang

Clin Mol Hepatol. 2009;15(2):253-256. Published online January 1, 1970

View: 2003 Download: 17

2009 EASL Highlights : Topics related to the therapy of hepatitis C

Jeong Heo

Clin Mol Hepatol. 2009;15(2):247-252. Published online January 1, 1970

View: 2047 Download: 16

2009 EASL Highlights : Topics related to hepatitis C

Byung Seok Lee

Clin Mol Hepatol. 2009;15(2):242-246. Published online January 1, 1970

View: 2017 Download: 15

2009 EASL Highlights : Topic related to the therapy of hepatitis B

Young Seok Kim

Clin Mol Hepatol. 2009;15(2):236-241. Published online January 1, 1970

View: 2001 Download: 14

2009 EASL Highlights : Topics related to hepatitis B

In Kyoung Kim

Clin Mol Hepatol. 2009;15(2):231-235. Published online January 1, 1970

View: 2028 Download: 15

7

The Korean Journal of Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma

Jeong Heo

Clin Mol Hepatol. 2009;15(2):227-230. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.227

View: 3997 Download: 26 Crossref: 1

6

Epithelioid hemangioendothelioma

Won Jae Lee

Clin Mol Hepatol. 2009;15(2):222-226. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.222

View: 4297 Download: 27

5

Primary angiosarcoma of the Liver

Jae Yeon Seok , Young Bae Kim

Clin Mol Hepatol. 2009;15(2):216-221. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.216

View: 4552 Download: 22 Crossref: 1

4

Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C

Hyung Min Kang, M.D., Myung Jin Park, M.D. Jeong-Min Hwang, M.D. Jin Wook Kim, M.D., Sook-Hyang Jeong, M.D.

Clin Mol Hepatol. 2009;15(2):209-215. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.209

View: 4639 Download: 35 Crossref: 3

A case of Liver metastasis of gastric hepatoid adenocarcinoma

Eun Hyoung Jeong, M.D., Dong Hyun Kim, M.D., Sung Ho Ma, M.D., Eui Jong Chung, M.D., Sang Su Bae, M.D., A Young Park, M.D. Hyung Jun Chu, M.D.

Clin Mol Hepatol. 2009;15(2):201-208. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.201

View: 4795 Download: 49 Crossref: 2

Viewed By 5504	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5404	MAFLD: How is it different from NAFLD?
Viewed By 5214	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5094	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4725	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Others